Bloom Syndrome, DNA analysis-13568

3/20/2023: This test order is currently unavailable. To order a referred alternate, place a MSO order for LabCorp (482370) GeneSeq PLUS

Test info

  
Bloom Syndrome, DNA analysis
  
13568
  
LAB13568
  
BLOOM
  
2281del6ins7 Mutation
Jewish heritage test
Sister chromatid exchange
  

Identification of carrier and affected individuals for the 2281del6ins7 mutation associated with Bloom syndrome in the Ashkenazi Jewish population.

Specimen

  
EDTA whole blood
  
  
7.0 mL
  
3.0 mL
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting

  

Lavender (EDTA), 4mL

  
ACD whole blood - 7mL
Amniotic fluid - 10 mL
Chorionic villus sample (CVS) (submission of maternal blood is required for fetal testing) - 20 mg
  

Whole blood:

Yellow ACD (A or B)

 

Amniotic fluid/CVS:

Sterile vial

  
Whole blood 7mL (minimum 3.0mL)
Amniotic fluid 10 mL (minimum 5mL)
Chorionic villus sample (CVS) 20 mg (minimum 10mg)
  

Yellow ACD (A or B)

Amniotic fluid: Sterile vial

CVS: two confluent T-25 flasks

  

Molecular Medicare billing request

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed
  

Ambient

Refrigerated

  
  • Frozen specimen
  • Hemolysis
  • quantity not sufficient for analysis (QNS)
  • Improper container

Performance

  
LabCorp RTP (512145): R-LC
  
Twice per week, or as needed
  
8 - 15 days
If cultured cells are needed, an additional 7 - 12 days may be required
  

Polymerase chain reaction (PCR), primer extension and flow-sorted bead

Clinical and Interpretive info

  

An interpretive report will be included

  

Prenatal testing is available. Bloom syndrome (OMIM 210900) is a rare autosomal recessive disorder that is characterized by small stature, photo-sensitivity, chromosomal instability, immunodeficiency, and a predisposition to develop multiple cancers. In the Ashkenazi Jewish population, the carrier frequency is approximately 1 in 104 individuals.

Billing

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81209
  
Yes
  
Result 51969-4
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed

Molecular Medicare billing request

Tracking

  
03/27/2019
  
01/02/2024
  
01/02/2024